The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study.

Jin Hwa SongSeo-Young YoonTae Yun ParkEun Young HeoDeog Kyeom KimHee Soon ChungJung-Kyu Lee

Published in: Respiratory research (2019)

DIH development during TB treatment does not significantly affect the clinical outcomes of pulmonary TB. However, treatment interruption caused by DIH may increase the risks of future relapse and acquired resistance. Further study is needed.

Keyphrases

drug induced
liver injury
mycobacterium tuberculosis
stem cells
pulmonary tuberculosis
current status
replacement therapy
climate change
hiv aids
hiv infected